Thomas Evans, DO
Dermatology · Medford, ORNPI 1568757086
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,609 of the $4,251 with a category attached, or 84.9%. 20 manufacturers reported payments, led by AbbVie at 34.9% of the total. 2025 is the largest year on record at $1,142, 2.8 times the $410 reported in 2019.
Across 172 payments — averaging $24.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$803
- Sarepta Therapeutics, Inc.$304
- Lilly USA, LLC$256
- UCB, Inc.$217
- Galderma Laboratories, L.p.$209
- plus $980 from 14 others
What the payments were for
- Travel & lodging$2015%
- Food & beverage$3,60985%
- Education$44010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $1,482 |
| Johnson & Johnson | 39 | $803 |
| Sarepta Therapeutics, Inc. | 7 | $304 |
| Lilly USA, LLC | 14 | $256 |
| UCB, Inc. | 7 | $217 |
| Galderma Laboratories, L.p. | 6 | $209 |
| Regeneron Healthcare Solutions, Inc. | 7 | $187 |
| Sanofi | 7 | $164 |
| Novartis | 4 | $111 |
| Pfizer | 1 | $105 |
| Bristol Myers Squibb | 1 | $90 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| LEO Pharma Inc. | 1 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Organogenesis Inc. | 1 | $23 |
| Dermavant Sciences, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $17 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,251 in reported general payments places this provider in the 70th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $221,525 |
| Humira(Cf) PenAdalimumab | 12 | $157,503 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $94,771 |
| Dupixent PenDupilumab | 12 | $44,904 |
| Fluorouracil | 111 | $7,891 |
| Clobetasol Propionate | 117 | $4,388 |
| Tacrolimus | 39 | $2,737 |
| Ketoconazole | 182 | $2,443 |
| Doxycycline Hyclate | 84 | $1,900 |
| Triamcinolone Acetonide | 174 | $1,521 |
| Tretinoin | 12 | $795 |
| Fluocinonide | 33 | $762 |
| Imiquimod | 28 | $492 |
| Desonide | 22 | $490 |
| Mupirocin | 47 | $318 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Medford
- Laurel GeraghtyMedford$6K
- Natasha ZacherMedford$4K
- Douglas NaversenMedford$4K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.